22 March 2019

In a collaborative effort, a team led by dr. Antonios Mikos (Rice University, Texas, US) and involving John Jansen en Jeroen van den Beucken, theme Reconstructive and regenerative medicine, has demonstrated in PNAS, the feasibility of an in vivo bioreactor-based strategy to generate vascularized bony tissue and its use for mandibular reconstruction.

The full publication in PNAS can be found via this link.

In more detail, the approach involved the simultaneous placement of polymeric chambers filled with autologous bone graft against sheep ribs and a polymeric space maintainer in a mandibular defect. During the 9-week period following this procedure, vascularized bone formed within the polymeric chamber and a soft tissue envelop formed around the space maintainer in the mandibular defect. Then, the generated vascularized bone in the in vivo bioreactor was harvested, the space maintainer removed, and the harvested bone tissue was used for mandibular reconstruction. This approach combining space maintenance in a mandibular defect and vascularized bone generation in an in vivo (3D-printed) bioreactor resulted in satisfactory surgical outcome in 5 of 6 of the mandibular defects in the used large animal model.

Jeroen van den Beucken
John Jansen

Related news items


Lowering cholesterol is not enough to reduce hyperactivity of the immune system

14 June 2019

In Cell Metabolism, Siroon Bekkering, theme Vascular damage, and colleagues, provides a novel potential explanation for the residual cardiovascular risk, related to persistent activation of the immune system in patients with hypercholesterolemia who are treated with statins.

read more

A warm welcome for the new forces at RIMLS

13 June 2019

RIMLS is now on full strength by welcoming new colleagues. Let us introduce them to you and find out what they can do for you.

read more

New cause for vaginal yeast infections discovered

13 June 2019

Martin Jaeger, theme Infectious diseases and global health, and colleagues, identified SIGLEC15 as a susceptibility factor in recurrent vulvovaginal candidiasis. Their findings were published in Science Translational Medicine.

read more

Internal KWF review procedure 2020

13 June 2019

In agreement with the existing policy the research board and Radboud Center for Oncology have decided to continue with the mandatory internal review procedure for KWF grant applications.

read more

A personal touch of Johan van der Vlag

13 June 2019

In order to promote interaction amongst colleagues within RIMLS, we have a ‘personal touch’ series setting employees in the spotlight. A light-hearted manner to learn about the colleagues you know and those you don’t. This week: Johan van der Vlag.

read more

Peter van der Kraan new theme leader Inflammatory diseases

13 June 2019

It is our pleasure to introduce Peter van der Kraan from the Dept. of Rheumatology, as the new leader of our theme Inflammatory diseases. As such he will be the successor of Irma Joosten who has done an outstanding job in the last years as theme leader, for which we thank her wholeheartedly.

read more